Similar Search Results

Applications of transport economics and imperfect competition

Meunier, David; Quinet, Emile - In: Research in Transportation Economics 36 (2012) 1, pp. 19-29

The great majority of analyses made in transport economics use, explicitly or, more often, implicitly, the common assumption of perfect competition. This is the case, for instance, when infrastructure projects are evaluated using the mere sum of the surpluses of transport users and providers....

Persistent link: https://www.econbiz.de/10010868654

Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation

Stargardt, Tom; Schreyogg, Jonas - In: Applied Health Economics and Health Policy 5 (2006) 4, pp. 235-247

Objective: Several EU countries are determining reimbursement prices of pharmaceuticals by cross-referencing prices of … direct and indirect impact of a price change depends mainly on the method applied to set reimbursement prices. When applying … cross-reference pricing, the reimbursement price is either determined by the lowest of foreign prices (e.g. Portugal), the …

Persistent link: https://www.econbiz.de/10005404742

Assessing the Impact of Global Price Interdependencies

Richter, Anke - In: PharmacoEconomics 26 (2008) 8, pp. 649-659

Documented launch delays and the ensuing debate over their underlying causes have focused on assessment from the individual country's perspective. Seen in a larger game theoretical framework this may cause problems, because although the countries see an individual game, the pharmaceutical firm...

Persistent link: https://www.econbiz.de/10005404838

Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios

Gress, Stefan; Niebuhr, Dea; May, Uwe; Wasem, Jurgen - In: PharmacoEconomics 25 (2007) 6, pp. 443-454

: regulation of reimbursement and pricing. We find that centralised regulation of reimbursement and pricing prevails in the 15 …, market approval is nearly always equivalent to reimbursement. Second, manufacturers are free to determine prices but internal … of prescriptions, three reform scenarios are feasible. The first scenario maintains centralised reimbursement and …

Persistent link: https://www.econbiz.de/10005404890

A pricing scheme for QoS in overlay networks based on first-price auctions and reimbursement

Amigo, Isabel; Belzarena, Pablo; Vaton, Sandrine - In: Netnomics 14 (2013) 1, pp. 69-93

been proposed, reimbursement proposals, while quite common in other scenarios as health, hotel reservation or airlines, are … willingness to pay and we model the reimbursement problem through a zero-sum Stackelberg game. We show that the Nash equilibrium …

Persistent link: https://www.econbiz.de/10010862872

The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?

Fattore, Giovanni; Jommi, Claudio - In: PharmacoEconomics 26 (2008) 1, pp. 5-15

principles for reimbursement and pricing, and the use of generic drugs to lower prices. As a result of these changes …

Persistent link: https://www.econbiz.de/10004990333

Waiting for Reimbursement of New Medicines in Canada: It's Time for a Rethink

Skinner, Brett J. - In: PharmacoEconomics 26 (2008) 8, pp. 629-632

drugs certified by Health Canada are finally approved by the provinces for public reimbursement. Publicly insured patients …

Persistent link: https://www.econbiz.de/10005449295

Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies

Godman, Brian; Haycox, Alan; Schwabe, Ulrich; Joppi, Roberta - In: PharmacoEconomics 26 (2008) 2, pp. 91-98

There are insufficient resources in the UK to fund all new technologies and new indications approved by the National Institute for Health and Clinical Excellence (NICE). Diverting funding from existing sources will have a detrimental effect on the provision of other priority services. The UK...

Persistent link: https://www.econbiz.de/10005449303

Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe

Wettermark, Bjorn; Godman, Brian; Andersson, Karolina; … - In: PharmacoEconomics 26 (2008) 7, pp. 537-550

the value and subsequent reimbursement of new and existing drugs, as well as reforms to obtain low prices for generic …

Persistent link: https://www.econbiz.de/10005243086

Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?

Puig-Junoy, Jaume - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 441-451

Background:Background: In many countries with generic reference pricing, generic producers and distributors compete by means of undisclosed discounts offered to pharmacies in order to reduce acquisition costs and to induce them to dispense their generic to patients in preference over others....

Persistent link: https://www.econbiz.de/10010585885